End of life: The Senate reopens the debate on assisted dying, people with disabilities are on alert
End of life: The Senate reopens the debate on assisted dying, people with disabilities are on alert

On Monday, May 11, the Senate will revisit the bill on assisted dying in its second reading, after more than a year of debate that has left its mark. The bill aims to create a regulated right: under certain conditions, a patient could receive a lethal substance administered by a healthcare professional or self-administer it. The government is aiming for final adoption by July, but the upper house, often more cautious on social issues, could tighten the provisions, significantly rewrite them, or even postpone the bill altogether.

Within patient and disability rights groups, the dividing line is clear. Some advocate for progress in the name of autonomy, the freedom to choose one's end, without pretense or dissimulation. Others, on the contrary, fear the negative consequences of legalization: when dependency, isolation, or precariousness take hold, freedom can quickly resemble a silent injunction, that of not "being a burden."

At the Luxembourg Palace, the safeguards at the heart of the battle

Facing the assembly, opponents brandished an argument that resonated with everyone: the potential speed of an assisted dying procedure compared to the sometimes interminable delays in accessing healthcare, pain management, or home care. The contrast was unsettling. When the state struggles to maintain control, some find it difficult to accept that it could suddenly organize the final act with almost impeccable administrative efficiency.

Supporters of the bill, however, defend a measure reserved for exceptional situations and promise that it will coexist with the development of palliative care. France already has a framework, the 2016 Claeys-Leonetti law, which authorizes, under strict conditions, deep and continuous sedation until death. The crux of the debate lies in determining whether this represents a further step, and at what legal, medical, and moral cost.

In the Senate, the sticking points have already been identified: eligibility criteria, deadlines, safeguards, the role of the physician, and conscientious objection. If the two chambers remain at odds, the National Assembly, which is generally favorable to the bill, will have the final say, giving the current debate the air of a final obstacle to be overcome… or reinforced. Before the final vote, associations and groups intend to exert their influence with concrete testimonies, and the underlying, unspoken question remains: in a society struggling to provide support, how can we guarantee that "choosing" never becomes the only option?

Community

Comments

Comments are open, but protected against spam. Initial posts and comments containing links undergo manual review.

Be the first to comment on this article.

Respond to this article

Comments are moderated. Promotional messages, automated emails, and abusive links are blocked.

Your first comment, or any message containing a link, may be placed pending approval.